2657 related articles for article (PubMed ID: 15266470)
1. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
2. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
3. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
4. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
5. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Bahadue FL; Soll R
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
[TBL] [Abstract][Full Text] [Related]
6. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Soll RF; Morley CJ
Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
[TBL] [Abstract][Full Text] [Related]
8. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
9. Continuous distending pressure for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
[TBL] [Abstract][Full Text] [Related]
10. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
Lemyre B; Davis PG; De Paoli AG; Kirpalani H
Cochrane Database Syst Rev; 2014 Sep; (9):CD003212. PubMed ID: 25188554
[TBL] [Abstract][Full Text] [Related]
11. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
[TBL] [Abstract][Full Text] [Related]
12. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
Soll R; Ozek E
Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Rojas-Reyes MX; Morley CJ; Soll R
Cochrane Database Syst Rev; 2012 Mar; (3):CD000510. PubMed ID: 22419276
[TBL] [Abstract][Full Text] [Related]
14. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
Lemyre B; Davis PG; De Paoli AG; Kirpalani H
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003212. PubMed ID: 28146296
[TBL] [Abstract][Full Text] [Related]
15. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive high-frequency ventilation in newborn infants with respiratory distress.
Abdel-Latif ME; Tan O; Fiander M; Osborn DA
Cochrane Database Syst Rev; 2024 May; 5(5):CD012712. PubMed ID: 38695628
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
[TBL] [Abstract][Full Text] [Related]
18. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
Subramaniam P; Ho JJ; Davis PG
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
[TBL] [Abstract][Full Text] [Related]
20. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
